Saltar al contenido
Merck

Renal effects of nitrendipine.

Journal of cardiovascular pharmacology (1991-01-01)
L M Ruilope
RESUMEN

Calcium-entry blockers exert several characteristic effects on the kidney that potentiate their antihypertensive effect. Long-term therapy with nitrendipine, a dihydropyridine derivative, lowers blood pressure while maintaining renal hemodynamics within limits similar to pretreatment values in essential hypertension with normal renal function. This is accompanied by a persistent natriuretic effect that probably facilitates its antihypertensive action and is not followed by changes of the renin-angiotensin-aldosterone system. Preliminary data also seem to indicate that nitrendipine could be safely used in patients with arterial hypertension and chronic renal failure.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Nitrendipine, >95%, powder
Nitrendipine, European Pharmacopoeia (EP) Reference Standard
Nitrendipine for peak identification, European Pharmacopoeia (EP) Reference Standard